ask="55.00"
ask_size="100"
average_daily_volume="1104010"
bid="23.00"
bid_size="100"
book_value="4.18"
change="+0.27"
change_from_200_day_moving_average="3.26"
change_from_50_day_moving_average="3.27"
change_from_52_week_high="-12.96"
change_From_52_week_low="9.40"
change_in_percent="+1.09%"
close="25.08"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.05"
ebitda="-278.87M"
eps_estimate_current_year="-4.89"
eps_estimate_next_quarter="-1.10"
eps_estimate_next_year="-3.76"
ex_dividend_date="N/A"
float_shares="44052000"
high="25.39"
high_52_weeks="38.04"
last_trade_date="1/23/2017"
last_trade_price="25.08"
last_trade_size="22131"
last_trade_time="4:00pm"
low="24.53"
low_52_weeks="15.68"
market_capitalization="1.42B"
moving_average_200_day="21.82"
moving_average_50_day="21.81"
name="Portola Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="27.89"
open="24.93"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+14.93%"
percent_change_from_50_day_moving_average="+14.97%"
percent_change_from_52_week_high="-34.07%"
percent_change_from_52_week_low="+59.95%"
previous_close="24.81"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.93"
price_per_sales="53.49"
revenue="26.23M"
shares_outstanding="56543000"
short_ratio="3.74"
stock_exchange="NMS"
symbol="PTLA"
volume="598193"
weeks_range_52="15.68 - 38.04"
